Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies

Clinical trial NCT07284927 · RECRUITING

Trial details

NCT number: NCT07284927
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma Acute Lymphoblastic Leukemia

Start date: 2025-12-03
Primary completion: 2026-12-03
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.